Immortals Review: What Its GLP-1 Prices Mean for Your First Payment

The most important number on an Immortals medication page is not necessarily the largest one. The platform displays monthly subtotals beside lower member prices, but the discounted figures carry a condition: quarterly billing with a three-month commitment paid upfront. That changes the practical question from “Can I afford this monthly price?” to “What will be collected after approval, and what else must I buy to receive this rate?” The consulted materials do not establish the price of the membership that unlocks those discounts.

Immortals presents itself as a longevity-focused telehealth platform connecting adults with physicians who may prescribe after reviewing their circumstances. Its offerings include compounded injectable tirzepatide and semaglutide with glycine and B12, plus listings for Wegovy, Zepbound KwikPen and Foundayo. This review examines the supplied documentation consulted October 19, 2026, rather than a purchased treatment experience. The central finding is a reasonably visible medication price menu paired with unresolved questions about the full bill, specific presentations and ongoing service responsibilities.

At a glance

Discounted billing: Displayed member medication prices require quarterly billing and a three-month commitment paid upfront; the membership fee is not established in the consulted materials.
Sources: [9] [12]
Compounded medication prices: Compounded injectable tirzepatide with glycine and B12 displays $255/month before membership and $217/month for members; compounded injectable semaglutide with glycine and B12 displays $196 and $167, respectively.
Sources: [9] [12]
Payment trigger: Immortals says payment occurs only after physician approval and that membership is not required to access treatment.
Sources: [8] [9]
Medication refunds: The Medicine policy states that all sales are final, with no returns or refunds, and directs customers to contact the company about suspected prescription-filling errors.
Sources: [10]
Separate testing subscription: Biomarker Tests costs $365/year and includes two annual rounds of blood panels and urine tests, plus platform access; it is not established as an included medication benefit.
Sources: [13]

Start with the amount collected, not the monthly label

Immortals separates access to treatment from access to its member discount. Its product language says no membership fees are required and that customers pay only after a doctor prescribes treatment. At the same time, the checkout-style displays promote savings with Immortals Membership. Those statements can coexist: membership may be optional for treatment while necessary for a particular discounted rate. What the supplied pages do not establish is the membership price or its complete conditions, preventing a reliable all-in comparison.

The asterisk matters equally. The displayed member prices are billed quarterly, with a three-month commitment paid upfront. They should not be read as month-to-month offers that can be ended after one monthly payment. The materials do not establish the corresponding nonmember collection schedule with the same clarity. Nor should a three-month payment commitment be treated as proof of the exact supply quantity, presentation or number of shipments a customer receives.

Before authorizing payment, request an itemized first-charge statement identifying the medication, membership charge if selected, billing period and any additional fees. Our guide to understanding the first GLP-1 payment explains why a monthly display and an initial debit can differ. Immortals does not identify these prices as introductory offers in the supplied extracts, but those extracts also do not establish a future price guarantee.

Sources: [8] [9] [12]

The medication menu has meaningful price and presentation differences

The table preserves the displayed monthly figures rather than converting them into an invented annual budget. Every member figure carries the quarterly upfront condition. The compounded listings identify glycine and B12 and describe weekly injectable forms; the tirzepatide listing also presents personalized-dose and microdose selections. The extracted pages do not establish which selection, strength or supply quantity each displayed price purchases. A product-specific quote is therefore more useful than comparing the lowest visible numbers alone.

The branded listings require similar care. Wegovy is identified as semaglutide with tablet and injection options, but the supplied text does not unambiguously connect its price to either presentation. Zepbound KwikPen is described as a weekly tirzepatide injection. Immortals identifies Foundayo as an orforglipron oral tablet taken daily; that is the provider’s product description, not an independent regulatory verification in this review. Do not assume that these listings represent interchangeable packages or equivalent services.

Several pages repeat a potential annual savings claim of $459 despite showing different monthly discounts. The supplied material does not explain that calculation or reconcile it across products. It is better to leave that promotional figure out of a personal budget than to treat it as established savings. The useful comparison is the actual written charge for the prescribed product, together with any membership payment and the services that charge covers.

Displayed medication prices; member amounts require quarterly billing and a three-month commitment paid upfront, with membership cost unresolved.
Listed product	Displayed subtotal	Displayed member price and presentation limits
Compounded tirzepatide with glycine and B12	$255/month	$217/month; weekly injectable listing; priced dose selection and quantity not confirmed
Compounded semaglutide with glycine and B12	$196/month	$167/month; weekly injectable listing; priced strength and quantity not confirmed
Wegovy (semaglutide)	$1,550/month	$1,317/month; tablet and injection options listed, but priced presentation unclear
Zepbound KwikPen (tirzepatide)	$600/month	$510/month; weekly injection listing; exact priced supply not confirmed
Foundayo (identified by provider as orforglipron)	$750/month	$637/month; daily oral tablet listing; exact priced supply not confirmed

Sources: [9] [12] [7] [6] [5]

Physician approval comes before payment, but inclusion details remain incomplete

Immortals says its intake takes approximately five to ten minutes and asks about medical history, current medications, goals and treatment preferences. A physician reviews each case before a prescription is issued, and prescribing is not guaranteed. Some states may require a synchronous audio or video consultation before approval. The provider describes product-page reviewers as U.S.-licensed, board-certified physicians; those are documentary claims, not credentials independently verified for this review.

The collection page says pricing varies by medication and dose, no insurance is required and charges occur only after physician approval. That is a useful payment boundary, but it does not answer every inclusion question. The supplied material does not clearly establish whether video consultations, injection materials, shipping or necessary laboratory work are included in each medication price. A broad “no hidden fees” statement is not a substitute for an itemized account of what a particular purchase provides.

The same distinction applies to insurance. Saying insurance is not required does not confirm that Immortals accepts insurance, submits prior authorizations or obtains coverage for a medication. NIDDK notes that coverage differs among plans and needs individual confirmation. Use a checklist of included GLP-1 costs to organize questions, then ask Immortals which services are bundled, which are optional and which might generate a separate bill.

Sources: [8] [9] [2]

Follow the service chain from review to follow-up

The provider publishes several different timing statements. Its collection page says physician review is typically completed within 24 hours, while product pages describe review within 72 hours. The collection says most medications ship in two to five business days after review and prescribing; a product page separately advertises an overall intake-to-door window of three to seven days. These are distinct claims, not a single guaranteed schedule. Shipment or dispatch should not be mistaken for arrival.

The tirzepatide page describes direct delivery in discreet packaging and advertises unlimited physician messaging, with video consultations available, for up to 12 months. It does not establish a response-time commitment, the cost treatment of video visits or how that support period relates to a three-month medication purchase. For budgeting, the important question is whether follow-up continues under the original payment or depends on another purchase, subscription or separately charged appointment.

The supplied materials do not name the dispensing pharmacies or clearly identify the clinical entity responsible for consultations and prescriptions. They also leave the carrier, tracking process, refrigeration requirements and delayed, damaged or lost-package procedures unresolved. FDA advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Obtain those contact paths before shipment rather than assuming a general delivery estimate explains how problems will be handled.

Sources: [8] [9] [1]

Renewal and refund rules affect the cost of changing course

The general terms identify Continuance LLC and its subsidiaries as the operator behind Immortals and several related brands. Those terms provide for automatic subscription renewal and require cancellation at least 24 hours before the current subscription period ends to avoid the next billing cycle. Billing may include applicable taxes and transaction fees. The supplied documents do not make clear how every general subscription provision maps onto each medication plan or prescription renewal, so that connection needs confirmation.

Cancellation is available through account settings under the general terms. It stops future charges and becomes effective at the end of the current subscription period; it does not itself reverse an existing payment. Separately, the Medicine policy says all sales are final and that refunds and returns are unavailable. It directs customers to contact the company if they believe a prescription-filling error occurred, without promising a particular remedy or reimbursement timetable.

The general terms also contemplate legal exceptions and discretionary refunds, but those provisions should not be converted into a routine refund entitlement. Ask which cancellation deadline applies to the selected medication arrangement and whether stopping renewal requires any additional action beyond account settings. Our explanation of cancellation versus refunds addresses this distinction. For a prepaid purchase, the key financial exposure is money already collected, not merely whether future renewal can be stopped.

Sources: [11] [10]

Biomarker testing is a separate budget decision

Immortals also sells a Biomarker Tests subscription for $365 a year. Its inclusion description specifies two comprehensive blood panels and urine tests annually, access to the Biomarkers platform, more than 100 unique biomarkers and at least 160 measurements. Those are not equivalent counting categories. The broader page uses other testing totals as well, so buyers should ask for the actual panel list rather than assuming every advertised number means a different unique biomarker.

Customers schedule both rounds through the platform at a local Quest Diagnostics laboratory. The program requires adulthood and U.S. residence and excludes Arizona, Hawaii, New Jersey, New York and Rhode Island in the supplied materials. Its FAQ says 95% of customers receive complete results within two weeks, despite a shorter promotional headline elsewhere. That is a provider-reported laboratory-results timeframe, not a medication delivery promise or a guarantee for every customer.

The testing page describes an HSA/FSA eligibility review and, if approved, a letter of medical necessity supplied in one to two days for submission with a receipt. That is not a guarantee of reimbursement or a documented medication-payment benefit. Nor does the evidence establish that this testing subscription is required for GLP-1 treatment. Keep it separate from the medication budget until Immortals explains whether any prescribed laboratory work overlaps with these panels.

Sources: [13]

A lower compounded price does not settle the medical comparison

Immortals distinguishes its compounded formulations from approved products, stating that compounded medications are not FDA approved and have not been evaluated by FDA for safety, quality or efficacy. FDA likewise explains that compounded preparations do not undergo its premarket review and recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. This is a clinical decision boundary, not simply a preference for the lowest listed price.

Nonapproval alone does not establish clinical inequivalence, and a brand-name product’s approval would not constitute approval of Immortals as a platform. The provider’s language about glycine, B12, personalization and longevity should also remain distinct from evidence of outcomes for its particular formulations. The supplied clinical research does not establish results for Immortals, vitamin blends or microdose offerings. A higher price does not prove better outcomes, just as a lower price does not prove comparable outcomes.

FDA has received reports of compounded-medication measurement and administration errors, including some associated with hospitalization. That does not establish an Immortals-specific event rate. It does make access to clear prescriber and pharmacist instructions part of the practical service evaluation. Our guide to comparing compounded and approved-drug prices explains why product identity and care responsibilities belong beside the dollar figure, without using a review to select a treatment or calculate a dose.

Sources: [8] [9] [12] [1] [3] [4]

Confirm location, access and responsibility before committing

Immortals Medicine advertises access for adults 18 and older in eligible U.S. states, with medication-specific restrictions. The tirzepatide page also says the product is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2, and that a physician will assess whether treatment is appropriate. Although its general terms list services across all 50 states, that does not establish access to every medication everywhere. The separate biomarker exclusions demonstrate why geography must be checked service by service. The consulted materials do not provide a medication-by-state list or establish the clinical BMI thresholds used by the platform, so general availability language cannot resolve an individual application.

The broader business connects longevity services, testing and digital tools. Immortals attributes its founding, alongside Blueprint, to Bryan Johnson and Kate Tolo. Its homepage describes the app and uploads of outside biomarker results as free, with prescriptions, panels and supplements optional, but also includes coming-soon language that leaves actual app availability inconsistent. The terms warn that AI tools do not provide medical advice and may be inaccurate. Free digital access should not be confused with free clinician care.

A useful prepayment request should therefore combine financial and operational details: the exact prescribed product, initial collection, membership terms, next renewal, included follow-up, dispensing pharmacy and cancellation route. Ask how to reach the responsible clinical team and pharmacy, not only a general support channel. The sample does not establish Spanish-language care or accessibility arrangements. These are practical matters to settle before an upfront commitment, rather than assumptions to discover after a final-sale medication purchase.

Sources: [14] [8] [11] [13]

Questions & answers

Is Immortals’ $217 tirzepatide price a monthly subscription without a commitment?

No. The displayed $217/month member figure for compounded injectable tirzepatide with glycine and B12 requires quarterly billing and a three-month commitment paid upfront. The page also displays a $255/month subtotal. Membership cost, the exact priced dose selection and supply quantity are not established in the supplied material. Ask for the actual initial charge and selected product rather than treating $217 as the amount necessarily collected at checkout.

Sources: [9]

Must I buy an Immortals membership to receive treatment?

The product page says membership fees are not required to access treatment, while separately advertising member discounts. Those are different propositions: access without membership does not mean access to the member rate. The consulted materials do not establish the membership’s price or full terms, so they cannot show whether joining reduces your total spending. Request both member and nonmember quotes with matching medication, presentation and service inclusions.

Sources: [9]

Will Immortals charge me if a physician does not approve treatment?

Immortals states that customers are charged only after a physician approves treatment, and it says prescriptions are not guaranteed. That is the documented payment trigger. The intake begins with medical and treatment-preference questions, and some states may require a live audio or video consultation. Before submitting payment authorization, confirm whether that approval-only charging policy covers every service you are selecting, particularly any separate testing or membership purchase.

Sources: [8] [9]

Can I get a refund by canceling an Immortals medication subscription?

Cancellation does not establish a refund. The Medicine policy says all sales are final, with no refunds or returns, and offers a contact route for suspected prescription-filling errors. General subscription terms say cancellation through account settings stops future charges at the end of the current period, with at least 24 hours’ notice before period-end to avoid renewal. Confirm how those general rules apply to your specific medication plan.

Sources: [10] [11]

Does the medication price include Immortals’ $365 biomarker subscription?

The supplied evidence presents Biomarker Tests as a separate annual subscription, not an established medication-price inclusion. It provides two yearly rounds of blood panels and urine tests, plus platform access, with appointments at Quest Diagnostics. Its geography restrictions also differ from broad Medicine availability. Ask whether your treatment requires laboratory work, whether that work is included in the medication price and whether purchasing this particular subscription is necessary.

Sources: [13] [8]

How quickly does Immortals say medication will arrive?

The documentation gives several estimates: review typically within 24 hours on the collection page, review within 72 hours on product pages, most medications shipping two to five business days after review and prescribing, and an overall three-to-seven-day intake-to-door claim. These statements are not interchangeable or a guaranteed arrival date. Ask which estimate applies to your order and how to contact the pharmacy or provider if the package is delayed or arrives compromised.

Sources: [8] [9]

Our assessment

Immortals provides useful visibility into its medication menu, displayed prices, approval-before-payment policy and advertised physician follow-up. Its clearest cost limitation is that the appealing member figures are not complete program prices: they require quarterly upfront payment, while membership cost and several service inclusions remain unresolved. The final-sale medication policy makes that incomplete picture more consequential. A reasonable next step is a written, product-specific quote identifying the first charge, membership terms, renewal, pharmacy and follow-up responsibilities. That would allow a meaningful comparison without assuming that a lower compounded price establishes clinical equivalence or that a branded listing guarantees a particular presentation. Until those details are settled, the pages support a preliminary budget—not a dependable all-in cost.

Visit Immortals’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Immortals Review: What Its GLP-1 Prices Mean for Your First Payment

At a glance

01Start with the amount collected, not the monthly label

02The medication menu has meaningful price and presentation differences

03Physician approval comes before payment, but inclusion details remain incomplete

04Follow the service chain from review to follow-up

05Renewal and refund rules affect the cost of changing course

06Biomarker testing is a separate budget decision

07A lower compounded price does not settle the medical comparison

08Confirm location, access and responsibility before committing